Treatment of malignant pleural effusion with the trifunctional antibody catumaxomab (Removab) (anti-EpCAM x Anti-CD3): results of a phase 1/2 study.
| Image |  |
|---|---|
| Description | scientific article published in February 2009 |
| Author/s |
author: Wolfgang Schuette |
| Publication date | February 1, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |